SENSEI BIOTHERAPEUTICS INC
SNSE
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Sensei Biotherapeutics is a clinical-stage biotechnology company developing cancer immunotherapies. The company's research and development pipeline is preclinical and clinical-stage, a process that typically requires extensive animal testing to evaluate drug safety and efficacy prior to human trials. The company's SEC filings explicitly reference reliance on animal studies as part of its development work.
Cruelty Free Investors, a firm specializing in screening for animal welfare risks, flags Sensei Biotherapeutics on its list of "Companies That Exploit Animals" for animal testing. This categorization indicates the company's business model is fundamentally reliant on animal experimentation to advance its therapeutic candidates, a practice excluded under the firm's animal exploitation policy.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.